{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:31Z","timestamp":1707524551605},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,11]]},"DOI":"10.7759\/cureus.24913","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:14:11Z","timestamp":1652289251000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Mustafa M","family":"Basree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Rudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Romaniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Kander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000224860","article-title":"Paraneoplastic syndromes in patients with urological malignancies","volume":"83","author":"Sacco E","year":"2009","unstructured":"Sacco E, Pinto F, Sasso F, Racioppi M, Gulino G, Volpe A, Bassi P. Paraneoplastic syndromes in patients with urological malignancies. Urol Int. 2009, 83:1-11. 10.1159\/000224860","journal-title":"Urol Int"},{"key":"ref2","article-title":"Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma","volume":"4","author":"Palapattu GS","year":"2002","unstructured":"Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol. 2002, 4:163-170.","journal-title":"Rev Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000458435","article-title":"Paraneoplastic peripheral nervous system manifestations of renal cell carcinoma: a case report and review of the literature","volume":"9","author":"Yang I","year":"2017","unstructured":"Yang I, Jaros J, Bega D. Paraneoplastic peripheral nervous system manifestations of renal cell carcinoma: a case report and review of the literature. Case Rep Neurol. 2017, 9:22-30. 10.1159\/000458435","journal-title":"Case Rep Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"33","author":"Darnell RB","year":"2006","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006, 33:270-298. 10.1053\/j.seminoncol.2006.03.008","journal-title":"Semin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02095-y","article-title":"Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature","volume":"21","author":"Zakrocka I","year":"2020","unstructured":"Zakrocka I, Baranowicz-G\u0105szczyk I, Korolczuk A, Za\u0142uska W. Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature. BMC Nephrol. 2020, 21:434. 10.1186\/s12882-020-02095-y","journal-title":"BMC Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-008-9675-5","article-title":"Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma","volume":"90","author":"Johnson V","year":"2008","unstructured":"Johnson V, Friedman N, Haller NA, Hagel C. Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma. J Neurooncol. 2008, 90:279-281. 10.1007\/s11060-008-9675-5","journal-title":"J Neurooncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7578","article-title":"Demyelinating peripheral neuropathy due to renal cell carcinoma","volume":"56","author":"Nishioka K","year":"2017","unstructured":"Nishioka K, Fujimaki M, Kanai K, et al.. Demyelinating peripheral neuropathy due to renal cell carcinoma. Intern Med. 2017, 56:101-104. 10.2169\/internalmedicine.56.7578","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2017.05.007","article-title":"Resolution of a debilitating paraneoplastic Parkinson-like neurological syndrome following tyrosine inhibitor therapy and consolidative nephrectomy in a patient with advanced clear cell renal cell\u00a0carcinoma","volume":"14","author":"Ali N","year":"2017","unstructured":"Ali N, Kutikov A, Geynisman DM. Resolution of a debilitating paraneoplastic Parkinson-like neurological syndrome following tyrosine inhibitor therapy and consolidative nephrectomy in a patient with advanced clear cell renal cell\u00a0carcinoma. Urol Case Rep. 2017, 14:18-20. 10.1016\/j.eucr.2017.05.007","journal-title":"Urol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000163053","article-title":"Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma","volume":"18","author":"Turk HM","year":"2009","unstructured":"Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, Ataergin S. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2009, 18:73-75. 10.1159\/000163053","journal-title":"Med Princ Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.038489","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Greenlee JE","year":"2004","unstructured":"Greenlee JE. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004, 75:1090. 10.1136\/jnnp.2004.038489","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.05.027","article-title":"A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies","volume":"89","author":"Fu P","year":"2021","unstructured":"Fu P, He L, Tang N, Nie Q, Li Z. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies. J Clin Neurosci. 2021, 89:336-342. 10.1016\/j.jocn.2021.05.027","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.040378","article-title":"Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage","volume":"75","author":"Rees JH","year":"2004","unstructured":"Rees JH. Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry. 2004, 75:43-50. 10.1136\/jnnp.2004.040378","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype","volume":"7","author":"Cortese A","year":"2020","unstructured":"Cortese A, Lombardi R, Briani C, et al.. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm. 2020, 7:10.1212\/NXI.0000000000000639","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura Y","year":"2015","unstructured":"Miura Y, Devaux JJ, Fukami Y, Manso C, Belghazi M, Wong AH, Yuki N. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 2015, 138:1484-1491. 10.1093\/brain\/awv054","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00464","article-title":"Paraneoplastic glomerulonephropathy associated with renal cell carcinoma","volume":"16","author":"Khurana A","year":"2020","unstructured":"Khurana A, Robila V, Massey HD, Paul AK. Paraneoplastic glomerulonephropathy associated with renal cell carcinoma. JCO Oncol Pract. 2020, 16:87-89. 10.1200\/JOP.19.00464","journal-title":"JCO Oncol Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420985323","article-title":"Paraneoplastic neurological syndromes: clinical presentations and management","volume":"14","author":"Devine MF","year":"2021","unstructured":"Devine MF, Kothapalli N, Elkhooly M, Dubey D. Paraneoplastic neurological syndromes: clinical presentations and management. Ther Adv Neurol Disord. 2021, 14:1756286420985323. 10.1177\/1756286420985323","journal-title":"Ther Adv Neurol Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21309.1","article-title":"Paraneoplastic diseases of the central nervous system","volume":"9","author":"Galli J","year":"2020","unstructured":"Galli J, Greenlee J. Paraneoplastic diseases of the central nervous system. F1000Res. 2020, 9:10.12688\/f1000research.21309.1","journal-title":"F1000Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-010-0066-9","article-title":"Treatment of paraneoplastic neurologic disorders","volume":"12","author":"Greenlee JE","year":"2010","unstructured":"Greenlee JE. Treatment of paraneoplastic neurologic disorders. Curr Treat Options Neurol. 2010, 12:212-230. 10.1007\/s11940-010-0066-9","journal-title":"Curr Treat Options Neurol"},{"key":"ref19","unstructured":"Kidney cancer. (2021). Accessed. April 26, 2022: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/kidney.pdf."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.030","article-title":"Addressing the best treatment for non-clear cell renal cell carcinoma: a meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies","volume":"83","author":"Ciccarese C","year":"2017","unstructured":"Ciccarese C, Iacovelli R, Brunelli M, et al.. Addressing the best treatment for non-clear cell renal cell carcinoma: a meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies. Eur J Cancer. 2017, 83:237-246. 10.1016\/j.ejca.2017.06.030","journal-title":"Eur J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30907-0","article-title":"Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study","volume":"20","author":"Mart\u00ednez Chanz\u00e1 N","year":"2019","unstructured":"Mart\u00ednez Chanz\u00e1 N, Xie W, Asim Bilen M, et al.. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. Lancet Oncol. 2019, 20:581-590. 10.1016\/S1470-2045(18)30907-0","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00152-5","article-title":"A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial","volume":"397","author":"Pal SK","year":"2021","unstructured":"Pal SK, Tangen C, Thompson IM Jr, et al.. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Lancet. 2021, 397:695-703. 10.1016\/S0140-6736(21)00152-5","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles G","year":"2017","unstructured":"Salles G, Barrett M, Fo\u00e0 R, et al.. Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience. Adv Ther. 2017, 34:2232-2273. 10.1007\/s12325-017-0612-x","journal-title":"Adv Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.744653","article-title":"Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis","volume":"12","author":"Greenlee JE","year":"2021","unstructured":"Greenlee JE, Carlson NG, Abbatemarco JR, Herdlev\u00e6r I, Clardy SL, Vedeler CA. Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis. Front Neurol. 2021, 12:744653. 10.3389\/fneur.2021.744653","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221575","article-title":"Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations","volume":"81","author":"Kroon FP","year":"2022","unstructured":"Kroon FP, Najm A, Alunno A, Schoones JW, Landew\u00e9 RB, Machado PM, Navarro-Comp\u00e1n V. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Ann Rheum Dis. 2022, 81:422-432. 10.1136\/annrheumdis-2021-221575","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92341-progressive-global-ataxia-with-sensory-changes-as-a-paraneoplastic-syndrome-in-a-patient-with-chromophobe-renal-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:22Z","timestamp":1707507622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92341-progressive-global-ataxia-with-sensory-changes-as-a-paraneoplastic-syndrome-in-a-patient-with-chromophobe-renal-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.24913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,11]]}}}